Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways - PubMed (original) (raw)
Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways
Wen Jiang et al. RSC Adv. 2012.
Abstract
Flavonoids, existing mainly as glycosides in nature, have multiple "claimed" beneficial effects in humans. Flavonoids are extensively metabolized in enterocytes and hepatocytes by phase II enzymes such as UGTs and SULTs to form glucuronides and sulfates, respectively. These glucuronides and sulfates are subsequently excreted via ABC transporters (e.g., MRP2 or BCRP). Therefore, it is the interplay between phase II enzymes and efflux transporters that affects the disposition of flavonoids and leads to the low bioavailability of flavonoid aglycones. Flavonoids can also serve as chemical regulators that affect the activity or expression levels of phase II enzymes including UGTs, SULTs and GSTs, and transporters including P-gp, MRP2, BCRP, OATP and OAT. In general, flavonoids may exert the inhibitory or inductive effects on the phase II enzymes and transporters via multiple mechanisms that may involve different nuclear receptors. Since flavonoids may affect the metabolic pathways shared by many important clinical drugs, drug-flavonoid interaction is becoming an increasingly important concern. This review article focused on the disposition of flavonoids and effects of flavonoids on relevant enzymes (e.g. UGTs and SULTs) and transporters (e.g. MRP2 and BCRP) involved in the interplay between phase II enzymes and efflux transporters. The effects of flavonoids on other metabolic enzymes (e.g. GSTs) or transporters (e.g. P-gp, OATP and OAT) are also addressed but that is not the emphasis of this review.
Keywords: ABC transporter; BCRP; MRP2; OAT; OATP; P-gp; SULT; UGT; disposition; flavonoids; glucuronidation; interplay; sulfonation.
Figures
Fig. 1
Cellular interplay between phase II enzymes and efflux transporters in flavonoid disposition.
Fig. 2
Effects of flavonoids on phase I and II enzymes and transporters in cells. The solid line represents the inhibition, whereas the dotted line represents the induction via various nuclear receptors.
Similar articles
- Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway.
Wang M, Yang G, He Y, Xu B, Zeng M, Ge S, Yin T, Gao S, Hu M. Wang M, et al. Mol Nutr Food Res. 2016 Sep;60(9):1967-83. doi: 10.1002/mnfr.201500321. Epub 2016 Jul 6. Mol Nutr Food Res. 2016. PMID: 26833852 Free PMC article. - Multiple ABC Transporters Efflux Baicalin.
Kalapos-Kovács B, Magda B, Jani M, Fekete Z, Szabó PT, Antal I, Krajcsi P, Klebovich I. Kalapos-Kovács B, et al. Phytother Res. 2015 Dec;29(12):1987-90. doi: 10.1002/ptr.5477. Epub 2015 Sep 24. Phytother Res. 2015. PMID: 26400418 - Metabolism of flavonoids in human: a comprehensive review.
Chen Z, Zheng S, Li L, Jiang H. Chen Z, et al. Curr Drug Metab. 2014 Jan;15(1):48-61. doi: 10.2174/138920021501140218125020. Curr Drug Metab. 2014. PMID: 24588554 Review. - Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.
Alvarez AI, Real R, Pérez M, Mendoza G, Prieto JG, Merino G. Alvarez AI, et al. J Pharm Sci. 2010 Feb;99(2):598-617. doi: 10.1002/jps.21851. J Pharm Sci. 2010. PMID: 19544374 Review.
Cited by
- Cadmium level in brain correlates with memory impairment in F1 and F2 generation mice: improvement with quercetin.
Halder S, Kar R, Chakraborty S, Bhattacharya SK, Mediratta PK, Banerjee BD. Halder S, et al. Environ Sci Pollut Res Int. 2019 Apr;26(10):9632-9639. doi: 10.1007/s11356-019-04283-2. Epub 2019 Feb 7. Environ Sci Pollut Res Int. 2019. PMID: 30734250 - Chromium Exposure in Late Gestation Period Caused Increased Levels of Cr in Brain Tissue: Association with Alteration of Activity and Gene Expression of Antioxidant Enzymes of F1 and F2 Generation Mice.
Halder S, Kar R, Chakraborty S, Banerjee BD. Halder S, et al. Biol Trace Elem Res. 2021 Jul;199(7):2635-2643. doi: 10.1007/s12011-020-02367-6. Epub 2020 Sep 5. Biol Trace Elem Res. 2021. PMID: 32892319 - Cancer chemoprevention through dietary flavonoids: what's limiting?
Amawi H, Ashby CR Jr, Tiwari AK. Amawi H, et al. Chin J Cancer. 2017 Jun 19;36(1):50. doi: 10.1186/s40880-017-0217-4. Chin J Cancer. 2017. PMID: 28629389 Free PMC article. Review. - Improved Bioavailability and Bioaccessibility of Lutein and Isoflavones in Cultured Cells In Vitro through Interaction with Ginger, Curcuma and Black Pepper Extracts.
Blank-Landeshammer B, Klanert G, Mitter L, Turisser S, Nusser N, König A, Iken M, Weghuber J. Blank-Landeshammer B, et al. Antioxidants (Basel). 2022 Sep 27;11(10):1917. doi: 10.3390/antiox11101917. Antioxidants (Basel). 2022. PMID: 36290641 Free PMC article. - Quercetin, Morin, Luteolin, and Phloretin Are Dietary Flavonoid Inhibitors of Monocarboxylate Transporter 6.
Jones RS, Parker MD, Morris ME. Jones RS, et al. Mol Pharm. 2017 Sep 5;14(9):2930-2936. doi: 10.1021/acs.molpharmaceut.7b00264. Epub 2017 May 31. Mol Pharm. 2017. PMID: 28513167 Free PMC article.
References
- Chun OK, Chung SJ, Song WO. J Nutr. 2007;137:1244. - PubMed
- de Vries JH, Janssen PL, Hollman PC, van Staveren WA, Katan MB. Cancer Lett. 1997;114:141. - PubMed
- Hertog MG, Hollman PC, Katan MB, Kromhout D. Nutr Cancer. 1993;20:21. - PubMed
- Narayana KR, Reddy MS, Chaluvadi MR, Krishna DR. Indian Journal of Pharmacology. 2001;33:2.
- Schroder G, Wehinger E, Lukacin R, Wellmann F, Seefelder W, Schwab W, Schroder J. Phytochemistry. 2004;65:1085. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous